Cat. No JK109200_100_G
J&K Chemical

Product Information

Product Name
2,3-Pyridinedicarboxylic acid, 99%
Brand Name
J&K
Product Number
109200
CAS
89-00-9
Molecular Formula
C7H5NO4
Molecular Weight
167.12
SDS Document
Certificate of Analysis (COA)​
COA not found

General Information

Synonyms
Quinolinic acid
PubChem CID
1066
IUPAC Name
pyridine-2,3-dicarboxylic acid
InChI Key
GJAWHXHKYYXBSV-UHFFFAOYSA-N
SMILES
C1=CC(=C(N=C1)C(=O)O)C(=O)O

Properties

Melting Point
188-190

Safety Information

Signal Word
Warning
Hazard Statement
H315
H319
H335
Precautionary Statement
P280
P321
P261
P271
P319
P405
P501
P302+P352
P332+P317
P362+P364
P264+P265
P305+P351+P338
P337+P317
P304+P340
P403+P233

References Data Source From Pubchem

Microbiome modulation in cancer immunotherapy

Publication Name: Nature Medicine
Publication Date: 2026-03-09
DOI: 10.1038/s41591-026-04285-x

Characterizing Human Oxidative, Anabolic and Glycolytic Metabolism in Athletes with Extreme Physiologies

Publication Name: Sports Medicine - Open
Publication Date: 2026-03-09
DOI: 10.1186/s40798-026-00989-z

Dysfunction of the CD38-Miro1 Axis Disrupts Astrocyte-neuron Mitochondrial Transfer in Alzheimer’s Disease: Mechanisms and Therapeutic Restoration

Publication Name: Journal of molecular neuroscience : MN
Publication Date: 2026-03-03
DOI: 10.1007/s12031-026-02490-4|10.1007/s12031-026-02531-y

Combining neurobiological markers and a sociodemographic risk score to predict adolescent depression – An IDEA RiSCo prospective cohort study

Publication Name: Molecular Psychiatry
Publication Date: 2026-03-02
DOI: 10.1038/s41380-026-03481-y

Rifaximin’s therapeutic spectrum: approved indications and experimental insights into emerging uses

Publication Name: Pharmacological reports : PR
Publication Date: 2026-02-23
DOI: 10.1007/s43440-026-00830-0

2,3-Pyridinedicarboxylic acid, 99%

Just added to your wishlist:
My Wishlist
You've just added this product to the cart:
Go to cart page